文献速递关节外科

体重指数与全关节置换术后感染:是否存在体重指数阈值证据

Weighing in on Body Mass Index and Infection After Total Joint Arthroplasty: Is There Evidence for a Body Mass Index Threshold?
PubMed 文献 · Clin Orthop Relat Res · 2018-01-01

受试者工作特征曲线下面积仅0.58,未找到明确BMI阈值;仅III级肥胖(BMI≥40 kg/m²)患者PJI风险升高(OR 3.09)。作者认为风险随BMI连续增加而无阈值,术前减重可能降低所有BMI高于正常者的感染风险。

要点

  • BMI预测90天PJI的ROC曲线下面积仅0.58,提示无明确阈值。
  • 仅III级肥胖(BMI≥40 kg/m²)患者PJI风险升高(OR 3.09,95%CI 1.46-6.54,p=0.003)。
  • 超重、I级肥胖、II级肥胖及体重过低患者PJI风险均未显著升高。

核心结论

  • 感染风险在整个BMI范围内逐渐增加,但不存在阈值。
  • 术前减重可能降低所有BMI高于正常者的感染风险。
  • BMI>40 kg/m²患者PJI风险约增高3倍,对此类患者须仔细权衡手术风险与获益。

研究设计与样本

  • 回顾性研究,纳入2006至2015年单中心所有初次全髋关节置换术(THA)和全膝关节置换术(TKA)患者。
  • 19226例患者符合纳入条件,因数据不完整排除1053例,最终队列18173例(TKA 8757例,THA 9416例)。
  • PJI采用国际共识会议(ICM)标准定义,识别指数手术后90天内的PJI。
  • BMI按美国疾病控制与预防中心(CDC)分类分析:体重过低≤18.49 kg/m²、正常18.5-24.9 kg/m²、超重25-29.9 kg/m²、I级肥胖30-34.9 kg/m²、II级肥胖35-39.9 kg/m²、III级肥胖≥40 kg/m²。
  • 采用逻辑回归分析并校正患者和手术危险因素,通过受试者工作特征(ROC)曲线和约登指数评估BMI阈值。

主要发现

  • BMI预测90天内PJI的ROC曲线下面积仅0.58(CI 0.52-0.63),提示该截断值并不比随机猜测好多少。
  • III级肥胖(≥40 kg/m²)患者90天内PJI风险升高(OR 3.09,95%CI 1.46-6.54,p=0.003)。
  • 超重患者PJI风险未升高(OR 0.72,95%CI 0.38-1.4)。
  • I级肥胖患者PJI风险未升高(OR 1.06,95%CI 0.57-2.0)。
  • II级肥胖患者PJI风险未升高(OR 1.08,95%CI 0.52-2.2);体重过低患者亦未升高(OR 1.80,95%CI 0.23-13.9)。

关键数值与推荐

  • PJI定义采用国际共识会议(ICM)标准。
  • BMI分类采用美国疾病控制与预防中心(CDC)标准:体重过低≤18.49 kg/m²、正常18.5-24.9 kg/m²、超重25-29.9 kg/m²、I级肥胖30-34.9 kg/m²、II级肥胖35-39.9 kg/m²、III级肥胖≥40 kg/m²。
  • PJI识别时间窗为指数手术后90天内。

临床怎么用

  • 作者认为术前减重可能降低所有BMI高于正常者的感染风险。
  • 作者指出对BMI>40 kg/m²患者,须仔细权衡手术风险与获益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although morbid obesity is considered a modifiable risk factor for periprosthetic joint infection (PJI), there is no consensus regarding an appropriate threshold for body mass index (BMI) above which a high risk for infection may outweigh the benefits of surgery. QUESTIONS/PURPOSES: (1) Is there a BMI cutoff threshold that is associated with increased risk for PJI? (2) Is the risk of PJI increased in higher obesity classes? METHODS: A retrospective study was conducted of all primary THAs and TKAs performed at one institution between 2006 and 2015. Overall 19,226 patients were eligible to be included in the study; 1053 patients were excluded as a result of incomplete data, resulting in a final cohort of 18,173 patients (8757 TKAs and 9416 THAs). PJI was defined using the International Consensus Meeting criteria. To ensure accurate followup, and because there is evidence to support the association between obesity and early infection, we identified PJI within 90 days of the index surgery. This relationship was examined separately for BMI as a continuous variable and for each BMI category as defined by the Centers for Disease Control and Prevention (underweight ≤ 18.49 kg/m; normal 18.5-24.9 kg/m; overweight 25-29.9 kg/m; obese class I 30-34.9 kg/m; obese class II 35-39.9 kg/m; obese class III ≥ 40 kg/m). Analyses were performed with logistic regression, accounting for both patient and surgical risk factors. A BMI threshold was evaluated with a receiver operating characteristic (ROC) curve and the Youden index. RESULTS: The area under the ROC curve for BMI and risk of PJI within 90 days was only 0.58 (confidence interval [CI], 0.52-0.63) suggesting such a cutoff was not much better than random chance. Among the BMI classes, patients with class III obesity (≥ 40 kg/m) were the only ones showing a higher risk for PJI within 90 days (odds ratio [OR], 3.09 [1.46-6.54]; p = 0.003). The risk of developing PJI was not greater for overweight (OR, 0.72; 95% CI, 0.38-1.4), class I obese (OR, 1.06; 95% CI, 0.57-2.0), or class II obese (OR, 1.08; 95% CI, 0.52-2.2) patients. Underweight patients also demonstrated no increased risk for PJI (OR, 1.80; 95% CI, 0.23-13.9). CONCLUSIONS: The risk for infection increases gradually throughout the full range of BMI, but no threshold exists. Weight reduction before surgery may mitigate risk for infection for all patients with a BMI above normal. Of note, patients with a BMI > 40 kg/m carried a threefold higher risk for PJI and for these patients, the risks of surgery must be carefully weighed against its benefits. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Shohat N, Fleischman A, Tarabichi M, et al. Weighing in on Body Mass Index and Infection After Total Joint Arthroplasty: Is There Evidence for a Body Mass Index Threshold? Clin Orthop Relat Res. 2018. PMID: 30794240. doi:10.1007/s11999.0000000000000141

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。